NDRG4 and obesity due to melanocortin 4 receptor deficiency: In multivariate analysis, among patients with tumor of reduced NDRG4 expression, obesity was found to be independently associated with increased risk of death, with adjusted HR to be 1.67 (95% CI: 1.07–2.60, P = 0.023).